Lesson of the week: Pitfalls in the diagnosis of phaeochromocytoma

British Medical Journal

Volumn 328, Issue 7440, 2004, Pages 629-630

  Zendron, L ^a   Fehrenbach, J ^a   Taverna, C ^b   Krause, M ^a  

^a Kantonsspital Muensterlingen   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANTIHYPERTENSIVE AGENT; CARBIDOPA; LEVODOPA;

ADRENALECTOMY; AGED; ANAMNESIS; ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; PHEOCHROMOCYTOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SYMPTOM; ADENOMA; ADRENAL TUMOR;

ADENOMA; ADRENAL GLAND NEOPLASMS; AGED; DIAGNOSTIC ERRORS; FEMALE; HUMANS; HYPERTENSION; PHEOCHROMOCYTOMA;

EID: 1642418447     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Williams GH. Hypertensive vascular disease. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine, 15th ed. New York: McGraw-Hill. 2001:1414-30.
2. Mantero F, Terzolo M., Arnaldi G, Osella G, Masini AM, Ali A, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637-44.
3. Montastruc JL, Chamontin B, Senard JM, Tran MA, Rascol O, Llau ME, et al. Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline. Lancet 1993;1:555.
4. Krentz AJ, Mikhail S, Cantrell P, Gavin MH. Pseudophaeochromocytoma syndrome associated with clozapine. BMJ 2001;322:1213.
5. Lenders WM, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma. JAMA 2002;287:1427-34.
6. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315-29.
7. Mochizuki T, Murase K, Tauxe WN, Tanada S, Hamamoto K. A pseudopheochromocytoma? Accumulation of I-123 MIBG in the renal pelvis. Clin Nucl Med 1994;19:1030-1.
8. 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-secreting adrenal tumours. Nucl Med Commun 2002;23:951-60.